Long-term treatment with atazanavir (ATV) in real life in Belgium: a retrospective observational cohort of 2264 HIV patients.

Stéphane De WitEric FlorenceLinos VandekerkhoveJean-Christophe GoffardBernard VandercamEric Van WijngaerdenMichel MoutschenRémy DemeesterPatrick LacorMarc DelforgeMaartje van FrankenhuijsenPaul Lacante

Published in: Acta clinica Belgica (2018)

Clinical and safety data from this 5 year-cohort study show that the vast majority of patients remained on ATV treatment for the first and second years, overall as well as patients treated with unboosted ATV and females.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
human immunodeficiency virus
hepatitis c virus
machine learning
smoking cessation